CD34 and p53 Immunohistochemical Stains Differentiate Hypocellular Myelodysplastic Syndrome (hMDS) from Aplastic Anemia and a CD34 Immunohistochemical Stain Provides Useful Survival Information for hMDS-Reference-Cited by-同舟云学术

CD34 and p53 Immunohistochemical Stains Differentiate Hypocellular Myelodysplastic Syndrome (hMDS) from Aplastic Anemia and a CD34 Immunohistochemical Stain Provides Useful Survival Information for hMDS

Published:2014-11-01 Issue:6 Volume:34 Page:426-432
ISSN:2234-3806
Container-title:Annals of Laboratory Medicine
language:en
Short-container-title:Ann Lab Med

Author:

Cha Choong-Hwan¹²,Park Chan-Jeoung¹,Chi Hyun-Sook¹,Seo Eul Ju¹,Jang Seongsoo¹,Cho Young-Uk¹,Lee Kyoo-Hyung³,Lee Je-Hwan³,Lee Jung-Hee³,Im Ho Joon⁴,Seo Jong-Jin⁴

Affiliation:

1. Departments of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea

2. Department of Laboratory Medicine, University of Ulsan College of Medicine and Gangneung Asan Hospital, Gangneung, Korea

3. Departments of Internal Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea

4. Departments of Pediatrics, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea

Funder

Asan Institute for Life Sciences, Asan Medical Center

Publisher

Annals of Laboratory Medicine

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

Link

https://synapse.koreamed.org/pdf/10.3343/alm.2014.34.6.426

Reference19 articles.

1. Hypoplastic Myelodysplastic Syndromes Can Be Distinguished From Acquired Aplastic Anemia by CD34 and PCNA Immunostaining of Bone Marrow Biopsy Specimens

2. Myelodysplastic Syndromes

3. Hypocellular myelodysplastic syndromes (MDS): new proposals

4. CD34/QBEND10 immunostaining in bone marrow biopsies: an additional parameterfor the diagnosis and classification of myelodysplastic syndromes

5. Significance of p53 overexpression in bone marrow biopsies from patients with bone marrow failure: aplastic anemia, hypocellular refractory anemia, and hypercellular refractory anemia

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic value of CD34 and CD117 Immunohistochemistry and Megakaryocyte Morphology in Myelodysplastic Syndromes: A Retrospective Case-control Study;Applied Immunohistochemistry & Molecular Morphology;2023-12-06

2. Evaluation of utility of immunohistochemistry markers as a tool for objective diagnosis of low-grade myelodysplastic syndrome in routine reporting: Prospective observational study;Indian Journal of Pathology and Microbiology;2022

3. Combined utility of CD177, P53, CD105 and c-kit immunohistochemical stains improves the detection of myelodysplastic syndrome;Annals of Diagnostic Pathology;2021-12

4. Immunoexpression of CD34, CD117, and p53 in Hypocellular Bone Marrow Disorders;Journal of Laboratory Physicians;2021-08-24

5. Differences in the bone marrow histology between childhood myelodysplastic syndrome with multilineage dysplasia and refractory cytopenia of childhood without multilineage dysplasia;Histopathology;2018-10-29